Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
DGX Quest Diagnostics
- 168.770
- +0.050+0.03%
Close Feb 14 16:00 ET
- 168.770
- 0.0000.00%
Post 20:01 ET
18.84BMarket Cap22.68P/E (TTM)
171.300High168.110Low1.33MVolume169.250Open168.720Pre Close224.97MTurnover1.20%Turnover Ratio21.95P/E (Static)111.62MShares171.30052wk High2.76P/B18.65BFloat Cap121.10152wk Low2.96Dividend TTM110.50MShs Float171.300Historical High1.75%Div YieldTTM1.89%Amplitude2.570Historical Low169.512Avg Price1Lot Size
About Quest Diagnostics Company
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Company Profile
SymbolDGX
Company NameQuest Diagnostics
Listing DateDec 17, 1996
Founded1967
CEOMr. James E. Davis
MarketNYSE
Employees48000
Fiscal Year Ends12-31
Address500 Plaza Drive
CitySecaucus
ProvinceNew Jersey
CountryUnited States of America
Zip Code07940
Phone1-973-520-2700
Company Executives
- Name
- Position
- Salary
- James E. Davis
- Chairman of the Board, President and Chief Executive Officer
- 12.67M
- Sam A. Samad
- Executive Vice President and Chief Financial Officer
- 3.98M
- Mark Delaney
- Senior Vice President and Chief Commercial Officer
- --
- Michael J. Deppe
- Senior Vice President, Corporate Controller and Chief Accounting Officer
- --
- Patrick Plewman
- Senior Vice President, Diagnostic Services
- --
- Catherine T. Doherty
- Senior Vice President, Regional Businesses
- 3.16M
- Michael E. Prevoznik
- Senior Vice President and General Counsel
- 2.25M
- Mark A. Gardner
- Senior Vice President, Molecular Genomics and Oncology
- --
- Karthik Kuppusamy
- Senior Vice President, Clinical Solutions
- 2.02M
- Robert B. Carter
- Independent Director
- --
- Denise M. Morrison
- Independent Director
- 312.33K
- Dr. Luis A. Diaz, Jr,M.D.
- Independent Director
- 280.41K
- Wright L. Lassiter, III
- Independent Director
- 300.44K
- Gary M. Pfeiffer
- Independent Director
- 342.12K
- Tracey C. Doi
- Independent Director
- 300.44K
- Timothy L. Main
- Independent Director
- 315.44K
- Timothy M. Ring
- Lead Independent Director
- 345.94K
- Vicky B. Gregg
- Independent Director
- 315.73K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
